Close

MiNK Therapeutics To Present Data Update From Allogeneic iNKT Cells in Solid Tumors at SITC 2023 Sep 27, 2023 09:05AM
MiNK Therapeutics to Participate in September Investor Conferences Aug 24, 2023 08:30AM
MiNK Therapeutics Reports Second Quarter 2023 Results Aug 10, 2023 07:30AM
MiNK to Provide Second Quarter 2023 Financial Report and Corporate Update Jul 28, 2023 08:30AM
MiNK Therapeutics Announces Virtual Annual Shareholders Meeting Jun 5, 2023 07:30AM


May 22, 2023 08:30AM MiNK Presents Clinical Data on Allogeneic iNKT Cells (agenT-797) in Severe Respiratory Distress at the American Thoracic Society International Conference
May 18, 2023 08:30AM MiNK's Novel FAP-CAR-iNKT Presented at ASGCT
May 18, 2023 08:30AM MiNK's Novel FAP-CAR-iNKT Presented at ASGCT
May 11, 2023 08:00AM MiNK Therapeutics Reports Corporate Update and First Quarter 2023 Financial Results
May 9, 2023 08:00AM Agenus Provides Corporate Update and First Quarter 2023 Financial Results
Apr 27, 2023 08:30AM MiNK Therapeutics to Report First Quarter 2023 Corporate Update and Financial Results
Apr 27, 2023 08:30AM MiNK Therapeutics to Report First Quarter 2023 Corporate Update and Financial Results
Apr 18, 2023 01:33PM MiNK Therapeutics (INKT) Announces Clinical Data on agenT-797
Apr 18, 2023 01:32PM MiNK Therapeutics Announces Clinical Data of Allogeneic iNKT Cells (agenT-797) in Solid Tumor Cancers at the AACR Annual Meeting
Apr 18, 2023 01:32PM MiNK Therapeutics Announces Clinical Data of Allogeneic iNKT Cells (agenT-797) in Solid Tumor Cancers at the AACR Annual Meeting
Mar 30, 2023 08:41AM Agenus Announces Dividend of 5 Million Shares of MiNK Therapeutics
Mar 21, 2023 08:00AM MiNK Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
Mar 21, 2023 08:00AM MiNK Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
Mar 15, 2023 08:45AM MiNK Therapeutics to Present Updated Clinical Data of allo-iNKT Cell Therapy in Solid Tumors at AACR Annual Meeting
Mar 15, 2023 08:45AM MiNK Therapeutics to Present Updated Clinical Data of allo-iNKT Cell Therapy in Solid Tumors at AACR Annual Meeting
Mar 7, 2023 09:00AM MiNK Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results
Mar 7, 2023 09:00AM MiNK Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results
Feb 16, 2023 09:28AM MiNK Therapeutics to Participate in HC Wainwright Cell Therapy Virtual Conference
Jan 11, 2023 02:25PM MiNK Therapeutics to Participate in B. Riley Securities Oncology Conference
Nov 17, 2022 09:00AM MiNK Therapeutics to Participate in Evercore ISI HealthCONx Conference
Nov 10, 2022 09:05AM MiNK Presents Clinical Data at SITC 2022 Showcasing iNKT Cell Therapy Pipeline
Mar 1, 2022 08:00AM Agenus Corporate Update and Fourth Quarter & Full Year 2021 Financial Report
Mar 1, 2022 08:00AM Agenus Corporate Update and Fourth Quarter & Full Year 2021 Financial Report
Nov 9, 2021 08:00AM Agenus Corporate Update and Third Quarter 2021 Financial Report
Nov 9, 2021 08:00AM Agenus Corporate Update and Third Quarter 2021 Financial Report
Oct 1, 2021 08:00AM MiNK Therapeutics to Present Three Abstracts on Novel Allogeneic iNKT Programs at SITC